Merck as a Contrarian Investment in pharmaceuticals Archives

daniel December 8, 2020December 8, 2020 Berkshire Hathaway (NYSE: BRK.B), Berkshire Hathaway (NYSE: BRK.B) is bullish on Merck (MRK, Can Merck Money without Coronavirus?, Is Buffett Right about Merck (MRK)?, Is Merck Making Money?, Merck (MRK), Merck & Co (MRK), Merck as a Contrarian Investment in pharmaceuticals, Merk & Company (NYSE: MRK), What Value Does Merck Have?

Is Buffett Right about Merck (MRK)?

Cancer treatment is a growing business in the United States. The National Cancer Institute estimates there will be 1.807 million new cases of cancer in the United States in 2020.